I have been diagnosed with bone cancer. I asked for a second opinion and was referred to a professor at a hospital. I have a meeting with him this week and he has mentioned a clinical trial Aspen which is a study of ALX148 in combination of pembrolizumab and chemotherapy. I would be interested to hear if anybody is currently involved with this trial
